BioGaia AB (publ)
BGLAF
$8.87
-$0.8517-8.76%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -17.36% | -3.67% | -22.37% | -3.77% | -11.47% |
| Total Depreciation and Amortization | 5.51% | 1.14% | 4.79% | -0.61% | 0.78% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 48.59% | 31.00% | 280.42% | 161.97% | 141.89% |
| Change in Net Operating Assets | 52.53% | -1,537.20% | -182.01% | -140.47% | -28.78% |
| Cash from Operations | -5.57% | -11.91% | 0.41% | 13.54% | 13.50% |
| Capital Expenditure | 89.88% | 71.24% | 18.66% | -12.16% | -278.30% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -332.58% | -164.75% | 81.52% | 75.17% | 65.90% |
| Cash from Investing | 89.31% | 70.69% | 19.25% | -11.30% | -272.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 12.09% | 13.02% | 0.89% | 12.99% | -0.13% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -134.22% | -134.22% | -134.22% | -134.22% | 9.23% |
| Other Financing Activities | -237.69% | -236.76% | 31.98% | 34.73% | 34.73% |
| Cash from Financing | -120.70% | -120.10% | -125.39% | -127.84% | 8.60% |
| Foreign Exchange rate Adjustments | -41.33% | 196.29% | -60.17% | -197.51% | -119.52% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -4,247.93% | -684.03% | -795.57% | -2,973.24% | 216.21% |